High doses of intravenous immunoglobulin G enhance Kupffer cell phagocytic function during the late phase of sepsis and endotoxemia in rats

Shock

Volumn 13, Issue 6, 2000, Pages 485-491

  Ito, Yoshiya ^a   Lukita Atmadja, Wahjuni ^a   Machen, Nancy W ^a   Baker, Gregory L ^a   McCuskey, Robert S ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Immunotherapy; Inflammation; Liver; Macrophages; Microcirculation

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE;

ANIMAL; ARTICLE; CELL ADHESION; DRUG EFFECT; ENDOTHELIUM; ENDOTOXEMIA; IMMUNOLOGY; INTESTINE PERFORATION; KUPFFER CELL; LIVER; MALE; MICROCIRCULATION; NEUTROPHIL; PATHOLOGY; PHAGOCYTOSIS; RAT; SEPSIS; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; CELL ADHESION; ENDOTHELIUM; ENDOTOXEMIA; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; INTESTINAL PERFORATION; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; MALE; MICROCIRCULATION; NEUTROPHILS; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS;

EID: 0034201447     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200006000-00011     Document Type: Article

References (34)

1. Mannick JA: Trauma, sepsis and immune defects. In Faist E, Meakins JL, Schildberg FW (eds): Host defense dysfunction in trauma: shock and sepsis. Berlin: Springer-Verlag, 1993, pp 15-21.
2. Ayala A, Chaundy IH: Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 6:S27-S38, 1996.
3. Ayala A, Ertel W, Chaundy IH: Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 5:79-90, 1996.
4. Ruiter DJ, Van der Meulen J, Brouwer A, Hummel MJR, Mauw BJ, Van der Ploeg JCM, Wisse E: Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest 45:38-45, 1981.
5. McCuskey RS, McCuskey PA, Urbaschek R, Urbaschek B: Kupffer cell function in host defense. Rev Infect Dis 9:S616-S619, 1987.
6. McCuskey RS: Hepatic microvasular response to endotoxemia and sepsis. Prog Appl Microcirc 19:76-84, 1993.
7. Dwyer JM: Manipulating the immune system with immune globulin. N Engl J Med 326:107-116, 1992.
8. Schedel I, Dreikhausen U, Nentwig B, Hoeckenschnieder M, Rauthman D, Balikciouglu S, Coldewey R, Deicher H: Treatment of gram-negative septic shock with an immununoglobulin preparation: a prospective, randomized clinical trial. Crit Care Med 19:1104-1113, 1991.
9. Pilz G, Kreuzer E, Kaab S, Appel R, Werdan K: Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients. Chest 105:76-82, 1994.
10. Zanetti G, Glauser MP: Use of intravenous immunoglobulins in high-risk surgical procedures and in posttrauma patients. In Lee ML and Strand V (eds): Intravenous immunoglobulins in clinical practice. New York: Marcel Dekker, 1997, pp 151-158.
11. Strand V: Proposed mechanisms for efficacy of intravenous immunoglobulin treatment. In Lee ML, Strand V (eds): Intravenous immunoglobulins in clinical practice. New York: Marcel Dekker, 1997, pp 23-36.
12. McCuskey RS, Nishida J, McDonnell D, Baker GL, Urbaschek R, Urbaschek B: Effect of immunoglobulin G on the hepatic microvascular inflammatory response during sepsis. Shock 5:28-33, 1996.
13. Baker GL, Machen NW, McCuskey RS: Intravenously administered immuoglobulins decrease neutophil recruitment in the livers of endotoxin treated rats. Shock 9 (Suppl):25, 1998.
14. Dominioni L, Gennari R, Interdonato PF, Festi L, Galozzi R, Dionigi R. Effect of high dose polyvalent IgG on defective bacterial phagocytosis in severe sepsis. Surg Res Commun 14:103-109, 1993.
15. Fujiwara T, Taniuchi S, Hattori K, Kobayashi T, Kinoshita Y, Kobayashi Y: Effect of immunoglobulin therapy on phagocytosis by polymorphonuclear leukocytes in whole blood of neonates. Clin Exp Immunol 107: 435-439, 1997.
16. Aukrust P, Muller F, Nordoy I, Haug CJ, Froland SS: Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo. Clin Exp Immunol 107:50-56, 1997.
17. Nishida J, Ekataksin W, McDonnell D, Urbaschek R, Urbaschek B, McCuskey RS: Ethanol exacerbates hepatic microvascular dysfunction, endotoxemia and lethality in septic mice. Shock 1:413-418, 1994.
18. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
19. McCuskey RS: Microscopic methods for studying the microvasculature of internal organs. In Baker CH, Nastuk WF (eds): Physical techniques in biology and medicine microvascular technology. New York: Academic Press, 1986, pp 247-264.
20. Yam LT, Li CY, Crosby WH: Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55:283-290, 1971.
21. Decker K: Biologically active products of stimulated liver macrophages. Eur J Biochem 192:245-261, 1990.
22. Ayala A, Perrin MM, Wang P, Chaundy IH: Sepsis induces an early increased spontaneous release of hepatocellular stimulatory factor (interleukin-6) by Kupffer cells in both endotoxin tolerant and intolerant mice. J Surg Res 52:635-641, 1992.
23. Kondo S, Wang D, Mayumi T, Klein AS, Bulkley GB: Effect of hemorrhagic shock and resuscitation upon hepatic phagocytic clearance and killing of circulating microorganisms. Shock 5:106-111, 1996.
24. Pilaro AM, Laskin DL: Accumulation of activated mononuclear phagocytes in the liver following lipopolysaccharide treatment of rats. J Leukoc Biol 40:29-41, 1986.
25. Huynh T, Baker CC, Bracey LW, Lemasters JJ: Adaptive Kupffer cell alterations after femur fracture trauma in rats. Am J Physiol 272:G1457-G1462, 1997.
26. Johnson SJ, Hines JE, Burt AD: Macrophage and perisinusoidal cell kinetics in acute liver injury. J Pathol 166:351-358, 1992.
27. Shi J, Fujieda H, Kokubo Y, Wake K: Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology 24:1256-1263, 1996.
28. McRitche DI, Girotti MJ, Rotstein OD, Teodorczk-Injean JA: Impaired antibody production in blunt trauma. Arch Surg 125:91-96, 1990.
29. Xu C, Poirier B, van Huyen JP, Lucchiari N, Michel O, Chevalier J, Kaveri S. Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases. Am J Pathol 153:1257-1266, 1998.
30. Baker GL, Ito Y, Machen NW, McCuskey RS: Intravenous immunoglobulin (ivIG) inhibits TNF? secretion from Kupffer cells and other macrophages stimulated by lipopolysaccharide (LPS). In Wisse E, Knook DL, Fraser R (eds): Cells of the hepatic sinusoids, VII. Leiden, The Netherlands: Kupffer Cell Foundation, 1999, in press.
31. Vollmar B, Glasz J, Menger MD, Messmer K: Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherance. Surgery 117:195-200, 1995.
32. Jaeschke H: Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 273 (Gastrointest Liver Physiol 36):G602-G611, 1997.
33. Horie Y, Wolf R, Anderson D, Granger DN: Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/ reperfusion. J Clin Invest 99:781-788, 1997.
34. Fehr J, Hofmann V, Kappeler U: Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 306:1254-1258, 1982.